Analysts think BEAT stock price could increase by 558%
Jul 14, 2025, 11:25 AM
-1.21%
What does BEAT do
HeartBeam, a development stage company based in Santa Clara, California, focuses on advanced cardiovascular diagnostic technology and went public on October 14, 2021. They are developing proprietary VECG technology and two patented products, HeartBeam AIMI and HeartBeam AIMIGo, for cardiac disease detection and monitoring.
3 analysts think BEAT stock price will increase by 558.06%. The current median analyst target is $8.16 compared to a current stock price of $1.24. The lowest analysts target is $8.08 and the highest analyst target is $8.40.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.